Tower Research Capital (TRC)’s Defiance Daily Target 2X Long ORCL ETF ORCX Stock Holding History

Tower Research Capital (TRC)’s Portfolio ORCX Stock Details ORCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$256	Sell	11 -348	-97%	-$13.5K	﹤0.01%	5084
2026 Q1	$9.58K	Buy	359 +302	+530%	+$10.6K	﹤0.01%	3923
2025 Q4	$2.95K	Buy	+57	New	+$4.83K	﹤0.01%	4446
2025 Q2	–	Sell	-33	Closed	-$1.26K	–	5653
2025 Q1	$1.26K	Buy	+33	New	+$1.69K	﹤0.01%	4749

Other funds holding ORCX

CCM

Capstone Capital Management Hong Kong $224M AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LFG

Larson Financial Group St Louis, Missouri $3.81B AUM 32.31% 1-Year Est. Return

Tower Research Capital (TRC)'s ORCX Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Defiance Daily Target 2X Long ORCL ETF (ORCX) stake by 97% in Q2 2026, selling an estimated $13.5K and leaving 11 shares worth $256. The position accounts for ﹤0.01% of the portfolio, ranked #5084.

Tower Research Capital (TRC) first reported a position in ORCX in Q1 2025 and has held it in 4 quarters since. The position peaked at $9.58K in Q1 2026. 13 funds tracked by Wall St. Rank hold ORCX as of Q2 2026.

Tower Research Capital (TRC) held 11 shares of Defiance Daily Target 2X Long ORCL ETF worth $256 as of Q2 2026.
Tower Research Capital (TRC) sold 348 Defiance Daily Target 2X Long ORCL ETF shares in Q2 2026, an estimated $13.5K.
Defiance Daily Target 2X Long ORCL ETF made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #5084 holding.
Tower Research Capital (TRC) first reported a position in Defiance Daily Target 2X Long ORCL ETF in Q1 2025 and has held it in 4 quarters since.
Tower Research Capital (TRC)'s Defiance Daily Target 2X Long ORCL ETF position peaked at $9.58K in Q1 2026.
13 funds tracked by Wall St. Rank held Defiance Daily Target 2X Long ORCL ETF as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.